Literature DB >> 15341894

Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.

Clete A Kushida1, Richard P Allen, Mark J Atkinson.   

Abstract

The objective of this study is to examine the causal relationships between the symptoms of restless legs syndrome (RLS) and specific clinical and subjective health-related, quality of life consequences. Structural equation modeling was applied to data from a questionnaire-based observational study. The RLS morbidities of decreased functional alertness and emotional distress in our sample of patients appear to be mostly secondary to the sleep disturbance associated with RLS. There was no clear indication of any other feature of RLS affecting these two aspects of RLS morbidity. A primary treatment goal should be the reduction of the sleep disturbance of RLS, both to decrease the RLS-related nocturnal distress and to improve daytime functioning.

Entities:  

Mesh:

Year:  2004        PMID: 15341894     DOI: 10.1016/j.sleep.2004.04.004

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  22 in total

1.  Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report.

Authors:  Ulrike H Mitchell
Journal:  J Med Case Rep       Date:  2010-08-23

2.  A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Authors:  Daniel O Lee; Ronald B Ziman; A Thomas Perkins; J Steven Poceta; Arthur S Walters; Ronald W Barrett
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

3.  Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.

Authors:  César Quiroz; Seema Gulyani; Wan Ruiqian; Jordi Bonaventura; Roy Cutler; Virginia Pearson; Richard P Allen; Christopher J Earley; Mark P Mattson; Sergi Ferré
Journal:  Neuropharmacology       Date:  2016-09-04       Impact factor: 5.250

4.  Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep.

Authors:  Richard P Allen; Peter B Barker; Alena Horská; Christopher J Earley
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

Review 5.  [Sleep and sleep disorders in the elderly: Part 3: Restless legs syndrome].

Authors:  H Frohnhofen; J Schlitzer
Journal:  Z Gerontol Geriatr       Date:  2015-06       Impact factor: 1.281

6.  Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Authors:  Magdolna Hornyak
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

7.  A Collaborative Paradigm for Improving Management of Sleep Disorders in Primary Care: A Randomized Clinical Trial.

Authors:  Jack D Edinger; Janet Grubber; Christi Ulmer; Jennifer Zervakis; Maren Olsen
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

8.  Excessive Daytime Sleepiness in Acute Ischemic Stroke: Association With Restless Legs Syndrome, Diabetes Mellitus, Obesity, and Sleep-Disordered Breathing.

Authors:  Pavel Šiarnik; Katarína Klobučníková; Pavol Šurda; Matúš Putala; Stanislav Šutovský; Branislav Kollár; Peter Turčáni
Journal:  J Clin Sleep Med       Date:  2018-01-15       Impact factor: 4.062

Review 9.  Restless legs syndrome: pathophysiology, diagnosis and treatment.

Authors:  Pankaj Satija; William G Ondo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.

Authors:  Diego Garcia-Borreguero; Jeffrey Patrick; Sarah DuBrava; Philip M Becker; Alan Lankford; Crystal Chen; Jeffrey Miceli; Lloyd Knapp; Richard P Allen
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.